Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

DEXCOM, INC.

(DXCM)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/11/2019 09/12/2019 09/13/2019 09/16/2019 09/17/2019 Date
146.7(c) 147.16(c) 146.26(c) 148.68(c) 153.7(c) Last
975 047 758 341 664 968 579 653 932 496 Volume
+1.01% +0.31% -0.61% +1.65% +3.38% Change
More quotes
Financials (USD)
Sales 2019 1 367 M
EBIT 2019 94,1 M
Net income 2019 35,0 M
Finance 2019 312 M
Yield 2019 -
Sales 2020 1 619 M
EBIT 2020 165 M
Net income 2020 116 M
Finance 2020 462 M
Yield 2020 -
P/E ratio 2019 376x
P/E ratio 2020 121x
EV / Sales2019 10,0x
EV / Sales2020 8,37x
Capitalization 14 015 M
More Financials
Company
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
09/17DEXCOM : Promotes Quentin Blackford to Chief Operating Officer
BU
09/17DEXCOM : Appoints Bridgette Heller to Board of Directors
BU
09/09DEXCOM : G6® CGM System Now Available In Canada
AQ
08/23DEXCOM : Court Rules that the Patents Asserted against Dexcom CGM Systems are In..
BU
08/02DEXCOM : Announces Upcoming Conference Presentations
BU
07/31DEXCOM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
07/31DEXCOM : 2Q Earnings Snapshot
AQ
07/31DEXCOM INC : Results of Operations and Financial Condition, Financial Statements..
AQ
07/31DEXCOM : Reports Second Quarter 2019 Financial Results
BU
07/29Devices for Diabetes Patients Spur Growth at Medical Firms
DJ
More news
Analyst Recommendations on DEXCOM, INC.
More recommendations
Sector news : Medical Equipment, Supplies & Distribution - NEC
09/16SANOFI : Abbott to Collaborate on Glucose Sensing, Insulin Delivery Data
DJ
09/14Companies ask judge in U.S. opioid trial to recuse himself
RE
09/10BAXTER INTERNATIONAL : to Buy Cheetah Medical for Up to $230 Million
DJ
09/04GLOBAL MARKETS LIVE : Boeing, Bayer, Purdue, KBC…
09/04STRYKER : to Buy Mobius Imaging, Cardan Robotics for Up to $500 Million
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 174,33  $
Last Close Price 153,70  $
Spread / Highest target 30,1%
Spread / Average Target 13,4%
Spread / Lowest Target -30,4%
EPS Revisions
Managers
NameTitle
Kevin Ronald Sayer Chairman, President & Chief Executive Officer
Jeffrey C. Moy Senior Vice President-Operations
Quentin Blackford Chief Financial Officer
Jacob Leach Senior Vice President-Research & Development
Jay S. Skyler Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.28.30%14 015
MEDTRONIC PLC20.21%146 309
BAXTER INTERNATIONAL INC.33.04%44 378
HOYA CORPORATION38.52%30 895
ZIMMER BIOMET HOLDINGS33.86%28 264
TERUMO CORP-46.03%21 931